Clinical trial
A Placebo-Controlled, Cross-Over Trial of Aripiprazole
NCT00351936 · North Suffolk Mental Health Association, Other · Completed
Key facts
| NCT number | NCT00351936 |
|---|---|
| Title | A Placebo-Controlled, Cross-Over Trial of Aripiprazole |
| Official title | A Placebo-Controlled, Cross-Over Trial of Aripiprazole Added to Obese Olanzapine-Treated Patients With Schizophrenia |
| Lead sponsor | North Suffolk Mental Health Association, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Aripiprazole, placebo |
| Enrollment | 16 |
| Start date | Dec 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Jul 13, 2006 |
| Last update posted | Feb 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: